Quick Answer
Unicycive Therapeutics, Inc. reported Total Revenue of $675.0 thousand for the year ending 2023.
- Unicycive Therapeutics, Inc. showed a decrease of -29.0% in Total Revenue from 2022 to 2023.
- This data is from Unicycive Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2022 to 2023 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $951.0 thousand | Q1 2023: $675.0 thousand.
- Historical annual values: Fiscal year 2023: $675.0 thousand | Fiscal year 2022: $951.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: